Know Cancer

or
forgot password

Evaluation of the Effect of Carum Carvi on Levels of Plasma Thyroid Hormones and TSH Level in Patients on Thyroid Hormone Therapy and Normal Controls.


Phase 1/Phase 2
18 Years
65 Years
Open (Enrolling)
Both
Thyroid Cancer Patients

Thank you

Trial Information

Evaluation of the Effect of Carum Carvi on Levels of Plasma Thyroid Hormones and TSH Level in Patients on Thyroid Hormone Therapy and Normal Controls.


Inclusion Criteria:



- Age 18-65

- Hypothyroid patients under treatment with levothyroxin

- Normal euthyroid patients with no goiter

Exclusion Criteria:

- Pregnancy or lactation

- Severe lung or gasterointestinal disease

- Heart failure or renal failure

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science

Outcome Measure:

Change of Thyroid and thyrotropin values from baseline at 2 and 6 weeks

Outcome Description:

TSH, Free T4, Free T3, T4RIA and T3RIA

Outcome Time Frame:

0-2-6 Weeks

Safety Issue:

Yes

Principal Investigator

Seyed Rasoul Zakavi, MD. IBNM

Investigator Role:

Principal Investigator

Investigator Affiliation:

Nuclear Medicine Research Center

Authority:

Iran: Ministry of Health

Study ID:

88498

NCT ID:

NCT01471288

Start Date:

May 2011

Completion Date:

Related Keywords:

  • Thyroid Cancer Patients
  • well differentiated thyroid cancer
  • Carum Carvi
  • Normal controls
  • Thyroid Neoplasms
  • Thyroid Diseases

Name

Location